Company Search:
Advanced Search
Sponsored Links
Proteome Sciences PLC Company Snapshot
Proteome Sciences PLC operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Proteome Sciences PLC with three other pharmaceutical manufacturers in Europe: Collagen Solutions PLC (2019 sales of £4.15 million [US$5.32 million] of which 100% was Biomaterials), Erytech Pharma SA of FRANCE (5.28 million Euros [US$6.22 million] of which 100% was Pharmacy), and Onxeo SA which is also based in FRANCE (4.29 million Euros [US$5.05 million] of which 82% was Oncology products).

Sales Analysis. During the year ended December of 2019, sales at Proteome Sciences PLC were £4.66 million (US$5.97 million). This is an increase of 52.7% versus 2018, when the company's sales were £3.05 million. Sales of Tmt Revenue saw an increase of 67.8% in 2019, from £2.21 million to £3.70 million. Not all segments of Proteome Sciences PLC experienced an increase in sales in 2019: sales of Grant Income fell 75.8% to £22,000.00 . (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Proteome Sciences PLC
  Stock Performance Chart for Proteome Sciences PLC
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 3.68p
(Figures in Pounds Sterling)
1 Week 13.2%   13 Weeks -3.4%  
4 Weeks -1.9%   52 Weeks 12.9%  
Proteome Sciences PLC Key Data:
  Ticker: PRM Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2019 Sales 4,656,000
(Year Ending Jan 2020).
Employees: 25
  Currency: Pounds Sterling Market Cap: 10,862,700
  Fiscal Yr Ends: December Shares Outstanding: 295,182,056
  Share Type: Ordinary Closely Held Shares: 60,819,615
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.